Timothy P. DiPeri

419 total citations
25 papers, 278 citations indexed

About

Timothy P. DiPeri is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Timothy P. DiPeri has authored 25 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Timothy P. DiPeri's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Fibroblast Growth Factor Research (3 papers). Timothy P. DiPeri is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Fibroblast Growth Factor Research (3 papers). Timothy P. DiPeri collaborates with scholars based in United States, Germany and South Korea. Timothy P. DiPeri's co-authors include Craig A. Stockmeier, Gregory A. Ordway, Jessica Crawford, Attila Szebeni, Katalin Szebeni, Michelle Chandley, Funda Meric‐Bernstam, Ming Zhao, Kurt W. Evans and Luke A. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Timothy P. DiPeri

20 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy P. DiPeri United States	8	98	62	59	46	45	25	278
Sylviane Ragot France	11	55 0.6×	92 1.5×	62 1.1×	14 0.3×	118 2.6×	18	358
Laura C. Kutz United States	6	51 0.5×	102 1.6×	7 0.1×	36 0.8×	84 1.9×	9	367
Tharani Sabaretnam Australia	8	23 0.2×	99 1.6×	28 0.5×	33 0.7×	39 0.9×	12	364
Roberta Zerlotin Italy	13	56 0.6×	173 2.8×	20 0.3×	27 0.6×	274 6.1×	30	432
Jianqun Han China	8	34 0.3×	151 2.4×	10 0.2×	21 0.5×	38 0.8×	12	322
Michael P. Brugts Netherlands	12	25 0.3×	149 2.4×	5 0.1×	39 0.8×	113 2.5×	16	399
Sanjay Munireddy United States	7	57 0.6×	76 1.2×	30 0.5×	81 1.8×	214 4.8×	9	411
Megan E. Dibbern United States	8	50 0.5×	108 1.7×	13 0.2×	52 1.1×	77 1.7×	15	316
Petra Eisele Switzerland	5	33 0.3×	185 3.0×	11 0.2×	25 0.5×	165 3.7×	8	341
Guimiao Chen China	6	13 0.1×	130 2.1×	18 0.3×	18 0.4×	91 2.0×	6	244

Countries citing papers authored by Timothy P. DiPeri

Since Specialization

Citations

This map shows the geographic impact of Timothy P. DiPeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy P. DiPeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy P. DiPeri more than expected).

Fields of papers citing papers by Timothy P. DiPeri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy P. DiPeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy P. DiPeri. The network helps show where Timothy P. DiPeri may publish in the future.

Co-authorship network of co-authors of Timothy P. DiPeri

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy P. DiPeri. A scholar is included among the top collaborators of Timothy P. DiPeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy P. DiPeri. Timothy P. DiPeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Evans, Kurt W., Maria Gabriela Raso, Dhruv Chachad, et al.. (2025). Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations. Molecular Cancer Therapeutics. 24(9). 1402–1414. 1 indexed citations

Russo, Ashley, Timothy P. DiPeri, Nicholas Nissen, et al.. (2024). Impact of primary tumor resection in the management of metastatic well‐differentiated neuroendocrine tumors of the small bowel and pancreas. Journal of Neuroendocrinology. 36(8). e13399–e13399.

DiPeri, Timothy P., Kurt W. Evans, Ming Zhao, et al.. (2024). Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer Discovery. 14(5). 828–845. 20 indexed citations

DiPeri, Timothy P., Kathleen Kong, Daniel D. Karp, et al.. (2023). Discordance of HER2 Expression and/or Amplification on Repeat Testing. Molecular Cancer Therapeutics. 22(8). 976–984. 7 indexed citations

DiPeri, Timothy P., Ming Zhao, Kurt W. Evans, et al.. (2023). Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma. Journal of Hepatology. 80(2). 322–334. 18 indexed citations

Zhao, Ming, Timothy P. DiPeri, Maria Gabriela Raso, et al.. (2023). Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan. npj Breast Cancer. 9(1). 66–66. 17 indexed citations

Saridogan, Turçin, Argun Akçakanat, Ming Zhao, et al.. (2023). Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Scientific Reports. 13(1). 20223–20223. 12 indexed citations

DiPeri, Timothy P., Kurt W. Evans, Maria Gabriela Raso, et al.. (2023). Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. Clinical Cancer Research. 29(21). 4385–4398. 17 indexed citations

DiPeri, Timothy P., Timothy E. Newhook, Laura R. Prakash, et al.. (2022). Prognostic significance of preoperative and postoperative CA 19‐9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first. Journal of Surgical Oncology. 126(6). 1021–1027. 6 indexed citations

10.

DiPeri, Timothy P., Daniel D. Karp, Siqing Fu, et al.. (2022). Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma. SHILAP Revista de lepidopterología. 5(1). 26–30.

11.

DiPeri, Timothy P., Timothy E. Newhook, Elsa M. Arvide, et al.. (2022). Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. Journal of the American College of Surgeons. 235(1). 41–48. 6 indexed citations

12.

DiPeri, Timothy P., Timothy E. Newhook, Hop S. Tran Cao, et al.. (2022). Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. Journal of Surgical Research. 278. 111–118. 4 indexed citations

13.

DiPeri, Timothy P., Yufei Chen, Anat Ben-Shlomo, et al.. (2022). Operative approach and case volume are associated with negative resection margins for adrenocortical carcinoma. Surgical Endoscopy. 36(12). 9288–9296. 6 indexed citations

14.

Li, Dali, Kurt W. Evans, Maria Gabriela Raso, et al.. (2021). Abstract P058: Anti-tumor activity of ATR inhibitor BAY 1895344 in patient-derived xenograft (PDX) models with DNA damage response (DDR) pathway alterations. Molecular Cancer Therapeutics. 20(12_Supplement). P058–P058.

15.

DiPeri, Timothy P., Yufei Chen, Anat Ben-Shlomo, et al.. (2021). Factors Associated with Non–Operative Management of Resectable Adrenocortical Carcinoma. Journal of Surgical Research. 267. 651–659. 3 indexed citations

16.

DiPeri, Timothy P., B. F. Cox, Jessica S. Crystal, et al.. (2020). Surgical resection at high volume centers is associated with improved overall survival in patients with stage I-Iii hepatocellular carcinoma. HPB. 22. S67–S68. 1 indexed citations

17.

Kim, Sungjin, Timothy P. DiPeri, Michelle Guan, et al.. (2020). Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy. World Journal of Gastrointestinal Surgery. 12(9). 377–389. 6 indexed citations

18.

Szebeni, Attila, Katalin Szebeni, Timothy P. DiPeri, et al.. (2016). Elevated DNA Oxidation and DNA Repair Enzyme Expression in Brain White Matter in Major Depressive Disorder. The International Journal of Neuropsychopharmacology. 20(5). pyw114–pyw114. 45 indexed citations

19.

Szebeni, Attila, Katalin Szebeni, Timothy P. DiPeri, et al.. (2014). Shortened telomere length in white matter oligodendrocytes in major depression: potential role of oxidative stress. The International Journal of Neuropsychopharmacology. 17(10). 1579–1589. 87 indexed citations

20.

Shiloni, Eitan, P Pouillart, J. Janssens, et al.. (1989). Sequential dacarbazine chemotherapy followed by recombinant interleukin-2 in metastatic melanoma. A pilot multicentre phase I-II study.. PubMed. 25 Suppl 3. S45–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact